17
The «Call to Action»: Rare cancers in all policies Paolo G. Casali [email protected]

Presentation of Rare Cancers in All Policies Call to Action

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Presentation of Rare Cancers in All Policies Call to Action

The «Call to Action»:

Rare cancers in all policies

Paolo G. [email protected]

Page 2: Presentation of Rare Cancers in All Policies Call to Action

a “Call to Action”…

Page 3: Presentation of Rare Cancers in All Policies Call to Action

www.rarecancerseurope.org

Page 4: Presentation of Rare Cancers in All Policies Call to Action
Page 5: Presentation of Rare Cancers in All Policies Call to Action

▪ Pediatric cancers

▪ Haematologic rare neoplasms

▪ Sarcomas▪ Rare thoracic cancers▪ Neuroendocrine tumours▪ Head & neck cancers▪ Central nervous system tumours ▪ Rare female genital cancers▪ Rare urological and male genital tumours▪ Endocrine gland tumours▪ Digestive rare cancers▪ Rare skin cancers & non-cutaneous melanoma

Eur J Cancer 2011;47:2493

Page 6: Presentation of Rare Cancers in All Policies Call to Action

ESMO Open. 2020;5(2):e000666

Page 7: Presentation of Rare Cancers in All Policies Call to Action

www.rarecancerseurope.org

Page 8: Presentation of Rare Cancers in All Policies Call to Action
Page 9: Presentation of Rare Cancers in All Policies Call to Action
Page 10: Presentation of Rare Cancers in All Policies Call to Action

▪ Conquering Cancer: Mission Possible

▪ Pharmaceutical Strategy for Europe

▪ Europe’s Beating Cancer Plan

▪ EU Research and Innovation Programme (2021-27) and Horizon Europe

▪ EU4Health and the European Semester Programmes

▪ Patients’ Rights in Cross-Border Healthcare

▪ A European Strategy for Data

▪ European Health Data Space

▪ Clinical Trials Regulation

▪ Proposal for a Regulation on Health Technology Assessment

▪ Orphan Medicinal Products and the Paediatric Regulations

▪ General Data Protection Regulation

Rare Cancers in All Policies

Page 11: Presentation of Rare Cancers in All Policies Call to Action
Page 12: Presentation of Rare Cancers in All Policies Call to Action
Page 13: Presentation of Rare Cancers in All Policies Call to Action
Page 14: Presentation of Rare Cancers in All Policies Call to Action
Page 15: Presentation of Rare Cancers in All Policies Call to Action
Page 16: Presentation of Rare Cancers in All Policies Call to Action
Page 17: Presentation of Rare Cancers in All Policies Call to Action

contact:

Rare Cancers Europe – ESMO

[email protected]

Thank you